VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AVDAmerican Vanguard Corporation
$2.63$75M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAVDFinancials

American Vanguard Corporation (AVD) Financials

30Y historyFree accessUpdated daily

Revenue growth remains highly inconsistent, fluctuating from a 9.0% contraction in 2025Q4 to a 6.7% increase in 2026Q1, while operating margins have frequently turned negative, including a -42.3% margin in 2024Q4.

AVD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue522.88M515.11M547.31M579.37M609.62M557.68M458.7M468.19M454.27M355.05M312.11M289.38M298.63M381.02M366.19M304.43M229.62M209.33M237.54M216.66M193.77M189.8M150.85M124.86M100.67M87.02M77.98M69.21M67M67.7M48.6M
Revenue Growth %-0.96%-5.88%-5.53%-4.96%9.31%21.58%-2.03%3.06%27.95%13.76%7.85%-3.1%-21.62%4.05%20.29%32.58%9.69%-11.88%9.64%11.81%2.09%25.81%20.82%24.03%15.69%11.59%12.67%3.3%-1.03%39.3%-12.27%
Cost of Goods Sold367.1M367.55M426.99M400.21M368.26M386.95M286.11M290.83M271.64M207.66M183.82M177.48M184.14M209.67M205.06M181.36M140.54M148.9M136.41M120.93M111.41M104.12M78.6M65.99M56.8M45.2M38.46M32.73M36.8M37.6M26M
COGS % of Revenue-71.35%78.02%69.08%60.41%69.39%62.37%62.12%59.8%58.49%58.9%61.33%61.66%55.03%56%59.57%61.2%71.13%57.43%55.82%57.5%54.86%52.1%52.85%56.42%51.94%49.32%47.3%54.93%55.54%53.5%
Gross Profit155.79M147.56M120.32M179.16M241.35M170.72M172.59M177.35M182.63M147.39M128.29M111.9M114.5M171.35M161.13M123.07M89.08M60.43M101.13M95.73M82.36M85.68M72.26M58.87M43.88M41.82M39.52M36.48M30.2M30.1M22.6M
Gross Margin %29.79%28.65%21.98%30.92%39.59%30.61%37.63%37.88%40.2%41.51%41.1%38.67%38.34%44.97%44%40.43%38.8%28.87%42.57%44.18%42.5%45.14%47.9%47.15%43.58%48.06%50.68%52.7%45.07%44.46%46.5%
Gross Profit Growth %-22.64%-32.85%-25.77%41.37%-1.08%-2.69%-2.89%23.91%14.89%14.64%-2.27%-33.18%6.34%30.92%38.15%47.42%-40.25%5.64%16.24%-3.88%18.57%22.73%34.18%4.92%5.81%8.35%20.79%0.33%33.19%-19.57%
Operating Expenses147.34M133.79M221.87M155.87M200.7M139.78M149.68M151.13M143.61M120.6M107.75M100.38M107.79M115.61M101.8M83.84M69.89M66.75M64.99M59.72M53.14M53.41M47.3M42.33M32M31.45M30.69M29.5M26.1M25.3M19.1M
OpEx % of Revenue-25.97%40.54%26.9%32.92%25.06%32.63%32.28%31.61%33.97%34.52%34.69%36.09%30.34%27.8%27.54%30.44%31.89%27.36%27.56%27.43%28.14%31.35%33.9%31.78%36.15%39.36%42.62%38.96%37.37%39.3%
Selling, General & Admin102.29M98.51M119.63M116.89M154.93M111.09M115.28M127.06M117.18M94.52M86.45M81.57M86.58M93.97M81.05M65.8M57.26M56.13M64.99M59.72M53.14M53.41M47.3M42.33M32M32.21M27.75M26.28M23M22.6M16.8M
SG&A % of Revenue-19.12%21.86%20.17%25.41%19.92%25.13%27.14%25.8%26.62%27.7%28.19%28.99%24.66%22.13%21.61%24.94%26.81%27.36%27.56%27.43%28.14%31.35%33.9%31.78%37.02%35.58%37.98%34.33%33.38%34.57%
Research & Development22.75M23.16M32.66M38.02M31.82M28.86M26.31M24.07M26.43M26.08M21.3M18.81M21.21M21.64M20.75M18.04M12.63M10.63M0000000000000
R&D % of Revenue-4.5%5.97%6.56%5.22%5.17%5.74%5.14%5.82%7.34%6.82%6.5%7.1%5.68%5.67%5.93%5.5%5.08%-------------
Other Operating Expenses4M12.12M69.58M957K13.95M-171K8.09M000000000000000000-761.9K2.95M3.21M3.1M2.7M2.3M
Operating Income8.44M13.77M-101.56M23.3M40.65M30.95M22.91M26.22M39.02M26.79M20.54M11.52M6.71M55.73M59.32M39.23M19.19M-6.33M36.14M36.01M29.22M32.27M24.96M16.54M11.88M10.37M8.83M6.98M4.1M4.8M3.5M
Operating Margin %1.61%2.67%-18.56%4.02%6.67%5.55%4.99%5.6%8.59%7.55%6.58%3.98%2.25%14.63%16.2%12.89%8.36%-3.02%15.22%16.62%15.08%17%16.54%13.25%11.8%11.91%11.32%10.08%6.12%7.09%7.2%
Operating Income Growth %-113.56%-535.95%-42.7%31.36%35.09%-12.63%-32.8%45.63%30.45%78.24%71.74%-87.96%-6.05%51.23%104.4%403.22%-117.51%0.36%23.26%-9.46%29.29%50.88%39.25%14.59%17.44%26.51%70.2%-14.58%37.14%-41.67%
EBITDA27.13M32.51M-79.01M45.08M62.79M57.12M42.81M44.86M57.91M43.75M36.87M28M23.04M70.58M72.81M52.77M33.57M7.16M47.76M46.1M35.89M39.28M30.76M20.59M14.22M12.51M11.78M10.19M7.2M7.5M5.8M
EBITDA Margin %5.19%6.31%-14.44%7.78%10.3%10.24%9.33%9.58%12.75%12.32%11.81%9.68%7.72%18.52%19.88%17.33%14.62%3.42%20.11%21.28%18.52%20.7%20.39%16.49%14.12%14.38%15.1%14.73%10.75%11.08%11.93%
EBITDA Growth %130.1%141.15%-275.28%-28.21%9.93%33.42%-4.58%-22.53%32.37%18.68%31.68%21.51%-67.35%-3.06%37.97%57.19%369.01%-85.01%3.59%28.45%-8.64%27.72%49.35%44.86%13.63%6.23%15.54%41.57%-4%29.31%-38.3%
D&A (Non-Cash Add-back)18.68M18.74M22.55M21.78M22.14M26.17M19.9M18.64M18.89M16.96M16.33M16.47M16.33M14.85M13.49M13.55M14.38M13.49M11.61M10.09M6.67M7.02M5.8M4.05M2.34M2.14M2.95M3.21M3.1M2.7M2.3M
EBIT-24.93M-30.53M-31.98M22.94M40.65M30.83M23.39M26.22M39.02M26.84M20.54M11.52M6.71M55.73M58.59M37.66M19.19M-6.33M36.47M36.01M29.22M32.27M24.96M16.54M11.88M10.37M8.62M6.98M4.1M4.8M3.5M
Net Interest Income-18.22M-16.56M-16.55M-12.27M-3.95M-3.62M-5.18M-7.21M-4.02M-1.94M-1.62M-2.56M-2.47M-1.19M-1.75M-3.46M-3.02M-3.21M-3.97M214K30K392K85K626K371.4K18.9K38.6K0000
Interest Income2K106K230K368K167K65K89K182K174K41K7K019K1K1K3K044K75K214K30K392K85K626K371.4K18.9K38.6K0000
Interest Expense18.22M16.67M16.78M12.64M4.12M3.69M5.27M7.39M4.2M1.98M1.63M2.14M2.49M1.19M1.75M3.46M3.02M3.25M4.3M000000000000
Other Income/Expense-51.59M-60.97M-18.9M-13M-4.69M-4.19M-4.59M-7.42M-5.42M-1.94M-1.62M-2.56M-3.07M-1.9M-2.47M-4M-3.02M-3.21M-3.97M-5.49M-2.69M-1.33M-1.23M-360K-602K-1.34M-1.43M-1.76M-900K-1.5M-900K
Pretax Income-43.15M-47.2M-120.46M10.3M35.97M26.75M18.32M18.8M33.6M24.85M18.92M8.96M3.64M53.83M56.85M35.22M16.17M-9.54M32.17M30.53M26.55M30.94M23.73M16.18M11.28M9.02M7.19M5.22M3.2M3.3M2.6M
Pretax Margin %-8.25%-9.16%-22.01%1.78%5.9%4.8%3.99%4.02%7.4%7%6.06%3.1%1.22%14.13%15.53%11.57%7.04%-4.56%13.54%14.09%13.7%16.3%15.73%12.96%11.2%10.37%9.21%7.55%4.78%4.87%5.35%
Income Tax2.42M2.68M5.88M2.78M8.56M8.17M3.08M5.2M9.14M4.44M5.54M2.01M-451K18.92M20.03M13.15M5.19M-3.75M12.15M11.8M11.07M11.94M9.26M5.92M4.23M3.38M2.87M1.99M1.1M1.3M1M
Effective Tax Rate %-5.6%-5.68%-4.88%26.98%23.8%30.52%16.81%27.67%27.22%17.88%29.29%22.42%-12.38%35.14%35.22%37.35%32.09%39.31%37.78%38.65%41.71%38.58%39%36.58%37.5%37.5%40%38.05%34.38%39.39%38.46%
Net Income-45.56M-49.88M-126.34M7.52M27.4M18.59M15.24M13.6M24.2M20.27M12.79M6.59M4.84M34.45M36.87M22.07M10.98M-5.79M20.02M18.73M15.45M19M14.48M10.26M7.05M5.64M4.31M3.24M2.1M2M1.6M
Net Margin %-8.71%-9.68%-23.08%1.3%4.5%3.33%3.32%2.9%5.33%5.71%4.1%2.28%1.62%9.04%10.07%7.25%4.78%-2.77%8.43%8.64%7.97%10.01%9.6%8.22%7%6.48%5.53%4.67%3.13%2.95%3.29%
Net Income Growth %66.58%60.52%-1780.28%-72.56%47.44%21.95%12.07%-43.79%19.34%58.54%94.02%36.15%-85.95%-6.56%67.06%100.91%289.74%-128.92%6.89%21.23%-18.7%31.26%41.06%45.6%24.99%30.81%33.25%54.07%5%25%-48.39%
Net Income (Continuing)-45.56M-49.88M-126.34M7.52M27.4M18.59M15.24M13.6M24.06M20.36M13.02M6.32M4.09M33.93M36.83M22.07M10.98M-5.79M20.02M18.73M15.45M19M14.48M10.26M7.05M5.64M4.31M3.24M2.1M2M1.6M
Discontinued Operations0000000000000000000000000000000
Minority Interest000000000254K167K-69K-634K-158K359K000000000000101.7K000
EPS (Diluted)-1.59-1.75-4.500.260.920.610.510.460.810.680.440.230.171.191.280.790.40-0.210.730.680.570.740.570.410.290.240.180.140.090.090.07
EPS Growth %67.56%61.11%-1830.77%-71.74%50.82%19.61%10.87%-43.21%19.12%54.55%91.3%35.29%-85.71%-7.03%62.03%97.5%290.48%-128.77%7.35%19.3%-22.97%29.82%39.02%41.38%20.83%33.33%28.57%59.45%-5.18%37.8%-48.31%
EPS (Basic)--1.75-4.500.270.940.620.520.470.830.700.440.230.171.221.320.800.40-0.210.750.710.600.780.610.440.300.250.180.140.090.090.07
Diluted Shares Outstanding28.65M28.43M28.06M28.53M29.87M30.41M29.99M29.66M30.05M29.7M29.39M29.24M28.91M28.9M28.76M27.88M27.65M27.12M27.47M27.44M27.19M25.76M25.56M24.84M24.24M23.66M24.06M23.96M24.22M20.04M23.94M
Basic Shares Outstanding28.65M28.43M28.06M28.13M29.23M29.81M29.45M29.03M29.33M29.1M28.86M28.67M28.44M28.3M27.91M27.56M27.39M27.12M26.64M26.31M25.93M24.34M23.95M23.5M23.12M22.95M23.67M23.96M24.22M20.04M23.94M
Dividend Payout Ratio---45.01%10.17%12.82%7.66%17.08%9.09%7.89%4.52%17.31%117.17%13.95%16.68%9.99%7.46%-10.62%9.81%14.01%8.16%8.12%7.86%8.5%8.15%10.54%4.62%9.52%10%6.25%

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Regulatory EPA molecule bans

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Volatility Amid Seasonal Shifts

As indicated by the most recent quarterly data, American Vanguard's revenue growth remains highly inconsistent, with a 6.7% increase in 2026Q1 following a 9.0% contraction in 2025Q4, reflecting the inherent challenges of managing a seasonal, agriculture-dependent portfolio in a volatile commodity price environment.

The revenue trajectory suggests that the company is struggling to maintain consistent demand, likely exacerbated by channel inventory de-stocking cycles. Investors should monitor whether the recent growth in 2026Q1 represents a sustainable recovery or merely a temporary rebound from the significant contraction observed in late 2025.

Structural Constraints on Gross Profit

Based on reported financial statements, gross margins have fluctuated significantly, bottoming out at 13.8% in 2024Q4 before recovering to 31.1% in 2026Q1, highlighting the sensitivity of the company's off-patent chemical portfolio to raw material cost spikes and inventory valuation adjustments.

The inability to consistently maintain gross margins above 30% suggests limited pricing power, as the company lacks the protection of new, proprietary molecules. This margin profile implies that profitability is highly susceptible to external cost pressures and the timing of regulatory-driven inventory write-downs.

Operating Leverage Remains Under Pressure

According to the income statement history, operating income has frequently turned negative, with a notable operating margin of -42.3% in 2024Q4, demonstrating that the company's fixed cost base is currently too high to support its fluctuating revenue levels during periods of operational stress.

The lack of consistent operating leverage indicates that SG&A and R&D expenses are not scaling efficiently with revenue. This suggests that management may need to rationalize the cost structure further if they are to achieve sustainable profitability in the absence of significant top-line growth.

Persistent Net Losses Cloud Earnings

As reported in recent filings, American Vanguard has struggled to generate positive net income, with a net margin of -9.68% recently, a trend that appears driven by both operational inefficiencies and the impact of non-operating items on the bottom line.

The recurring net losses warrant further investigation into whether these are purely operational or if they reflect ongoing impairments related to the legacy portfolio. Investors should be cautious of the quality of earnings until the company can demonstrate a sustained return to positive net income.

Regulatory Risks Threaten Core Portfolio

Based on the provided data and industry context, the most significant risk to the income statement is the potential for accelerated EPA restrictions on organophosphates, which could render a substantial portion of the company's revenue-generating assets obsolete in the near term.

Short-sellers would likely focus on the vulnerability of the company's legacy chemical portfolio to regulatory shifts, which could force expensive portfolio turnover. This risk profile suggests that the current valuation may not fully account for the potential loss of key revenue streams due to environmental compliance.

AVD — Frequently Asked Questions

Quick answers to the most common questions about buying AVD stock.

What was American Vanguard Corporation's (AVD) revenue in 2025?

For fiscal year 2025, American Vanguard Corporation (AVD) reported total revenue of $515.1M. This represents a 959.9% increase compared to $48.6M in 1996.

Is American Vanguard Corporation (AVD) profitable?

American Vanguard Corporation (AVD) reported a net loss of $49.9M for the fiscal year ending 2025.

What is American Vanguard Corporation's operating profit margin?

American Vanguard Corporation (AVD) reported an operating income of $13.8M, resulting in an operating profit margin of 2.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is American Vanguard Corporation's gross profit and gross margin?

American Vanguard Corporation (AVD) generated $147.6M in gross profit for the year, representing a gross profit margin of 28.6%. This demonstrates the company's core pricing power and production efficiency.